AGP Executive Report
Last update: 5 hours agoCancer Care in the NHS: NICE has recommended Henlius’ PD-1 immunotherapy Hetronifly® (serplulimab) for routine use in England and Wales, expanding options for extensive-stage small cell lung cancer alongside standard chemotherapy. Cardiac Monitoring at Home: ESC 2026 highlights VIRTUES trial results showing a virtual e-health system can safely monitor pacemakers and ICDs, aiming to cut clinic burden while keeping patients satisfied. Health Research Breakthrough: A Nature study links bat immune-gene adaptations to longevity and cancer resistance, suggesting pathogen-driven DNA changes may help explain their unusual health span. Public Health Alert: The Dutch Trimbos Institute issued a red warning after ecstasy pills mimicking Donald Trump were found to contain PMMA, which can delay effects and raise overdose risk. Mental Health Through Movement: A Latvian long-distance walker says his world trek helps manage depression and stress, describing daily walking as “like my SSRI.” Food & Diet Insight: A new report explores how diet patterns can affect cataract risk, adding to the growing push for prevention-focused nutrition. Migration & Health Policy: Rwanda is in talks with several European countries about migrant transit centres, raising fresh questions about health access and safeguards.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
